[EN] ALKYLPYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF [FR] INHIBITEURS DE LA F1FO-ATPASE À BASE D'ALKYLPYRAZOLYL GUANIDINE ET APPLICATIONS THÉRAPEUTIQUES ASSOCIÉES
[EN] ALKYLPYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF<br/>[FR] INHIBITEURS DE LA F1FO-ATPASE À BASE D'ALKYLPYRAZOLYL GUANIDINE ET APPLICATIONS THÉRAPEUTIQUES ASSOCIÉES
申请人:LYCERA CORP
公开号:WO2015089131A1
公开(公告)日:2015-06-18
The invention provides pyrazolyl guanidine compounds that inhibit F1Fo-ATPase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.